🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase I, Randomized, Parallel-group, Double-Blind, Placebo-Controlled, Sing...
Status
Completed
Location
Research Site
Start Date
2015-11-11
Trial ID
NCT02542605
Treatments Being Tested
A pharmacokinetic drug interaction study of erenumab and an oral contracept...
Status
Completed
Location
Research Site
Start Date
2016-02-12
Trial ID
NCT02792517
Treatments Being Tested
Many people with migraine also experience tinnitus - a persistent ringing, ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07
Trial ID
NCT07655440
A study to evaluate the effect of erenumab compared to placebo on the chang...
Status
Completed
Location
Research Site
Start Date
2013-08-06
Trial ID
NCT01952574
Treatments Being Tested
The primary objective of this study was to assess the effects of subcutaneo...
Status
Completed
Location
Research Site
Start Date
2016-02-22
Trial ID
NCT02741310
Treatments Being Tested
This study will evaluate the efficacy and safety of erenumab in migraine pr...
Status
Completed
Location
Paradigm Clinical Research Center Inc
Start Date
2019-09-05
Trial ID
NCT03832998
Treatments Being Tested
This study will evaluate the potential for a pharmacokinetic (PK) interacti...
Status
Completed
Location
QPS
Start Date
2019-09-26
Trial ID
NCT04179474
Treatments Being Tested
It is planned to include 10000 patients. In the China HeadAche DIsorders Re...
Status
Recruiting
Location
Anqing Municipal Hospital
Start Date
2022-08-29
Trial ID
NCT05334927
The purpose of this study is to determine if AMG 334 is effective in treati...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-03-20
Trial ID
NCT03096834
Treatments Being Tested
Migraine is a very common, neurological disorder, characterized by recurren...
Status
Withdrawn
Location
Novartis Investigative Site
Start Date
2019-10-30
Trial ID
NCT04114630
Treatments Being Tested